Related healthcare insights
Article
Value-based contracts can present challenges that must be overcome to bring gene therapies to market.
Article
FDA reaches agreement with life sciences segment of Optum to provide data and expertise to evaluate and research biologics and vaccines.
Article
Old strategies and new challenges don’t mix. Future-proof your plan and get better predictability with new pricing models and risk management tools.